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In an era when healthcare expenditure continue to rise
progressively worldwide, it is becoming increasingly important
to make decisions about the allocation of healthcare resources
based on information about the comparative burdens of different
disorders. Burden can be defined in terms of condition-specific
rates or morbidity and mortality,1 but research is increasingly
moving beyond these actuarial data to consider additional
information about the impairments caused by different disorders,
such as the comparative effects of conditions on days out of role2,3
or role performance.4–8 A weakness of previous research is that
most studies estimated the extent to which disorders are
associated with being totally out of role (i.e. the number of days
a person is not at all able to perform as usual).9 But there is
growing evidence that disorders are also associated with partial
disability (i.e. the number of days a person is partially unable to
perform as usual).10 Moreover, partial disability now may predict
full disability later.11 These suggestions make the study of partial
disability particularly interesting. Investigating partial disability
enables us to study the potential broader influence that disorders
may have on functional impairment, over and above full disability.
There are three important limitations in previous research. First,
there are no cross-national analyses on the comparative impact
of mental and physical disorders on partial disability. Second,
most studies estimated the impact of disorders in the workplace
(e.g. Dewa & Lin,4 Dewa et al5,12), but studies that go beyond
work productivity are much scarcer. Third, most previous research
estimated individual effects of mental/physical health on role
disability, i.e. the effects of disorders on the daily lives of those
who have a disorder, but a public-health societal approach has
never been used before.
The current study builds on earlier World Mental Health
studies reporting on the impact of mental and physical disorders
on total role impairment.13 The specific aims of the study were to
investigate: (a) the total number of partial disability days per month
of respondents with mental and physical disorders; (b) the number
of additional partial disability days per month due to mental and
physical disorders among those with a disorder (‘individual-level
effects’); (c) the attributable proportion of mental and physical
disorders in the number of partial disability days in the society
(‘societal-level effects’) using population-attributable risk
proportions; (d) differences in individual and societal effects of
disorders in specific subdomains of partial disability; and (e) the
extent to which there are differences in the effects of disorders
on partial disability across different income categories.
Method
Sample
The World Mental Health (WMH) Surveys were carried out in 26
samples worldwide: Africa (Nigeria, South Africa); the Americas
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Background
Mental and physical disorders are associated with total
disability, but their effects on days with partial disability (i.e.
the ability to perform some, but not full-role, functioning in
daily life) are not well understood.
Aims
To estimate individual (i.e. the consequences for an individual
with a disorder) and societal effects (i.e. the avoidable partial
disability in the society due to disorders) of mental and
physical disorders on days with partial disability around the
world.
Method
Respondents from 26 nationally representative samples
(n=61 259, age 18+) were interviewed regarding mental and
physical disorders, and day-to-day functioning. The
Composite International Diagnostic Interview, version 3.0
(CIDI 3.0) was used to assess mental disorders; partial
disability (expressed in full day equivalents) was assessed
with the World Health Organization Disability Assessment
Schedule in the CIDI 3.0.
Results
Respondents with disorders reported about 1.58 additional
disability days per month compared with respondents
without disorders. At the individual level, mental disorders
(especially post-traumatic stress disorder, depression and
bipolar disorder) yielded a higher number of days with
disability than physical disorders. At the societal level, the
population attributable risk proportion due to physical and
mental disorders was 49% and 15% respectively.
Conclusions
Mental and physical disorders have a considerable impact on
partial disability, at both the individual and at the societal
level. Physical disorders yielded higher effects on partial
disability than mental disorders.
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(Brazil, Colombia, Mexico, USA), Asia and the Pacific (Japan,
New Zealand, in the People’s Republic of China: Beijing, Shanghai
and Shenzhen), Europe (Belgium, Bulgaria, France, Germany,
Italy, The Netherlands, Northern Ireland, Portugal, Romania,
Spain, Ukraine); and the Middle East (India, Israel, Lebanon,
Iraq). Respondents were selected in most WMH countries using
a stratified multistage clustered-area probability sampling strategy.
The total sample size was 121 902, with individual country sample
sizes ranging from 2357 in Romania to 12 790 in New Zealand.
The weighted average response rate across all countries was
72.0%. Using World Bank criteria,14 countries were classified as
low-income (China, Colombia, India, Iraq, Nigeria and Ukraine),
middle-income (Brazil, Bulgaria, Lebanon, Mexico, Romania and
South Africa) and high-income countries (Belgium, France,
Germany, Israel, Italy, Japan, The Netherlands, New Zealand,
Northern Ireland, Spain, Portugal and USA). More information
on the sample characteristics is reported elsewhere.15
Procedures
Surveys were conducted face to face by trained lay interviewers.
Informed consent was obtained before beginning interviews.
During interviews, all respondents provided sociodemographic
and core diagnostic information. Internal subsampling was used
to reduce respondent burden and average interview time and cost
by dividing the interview into two parts. Part 1 included the core
diagnostic assessment of mental disorders. Part 2 included
additional information relevant to a wide range of survey aims,
including the assessment of physical disorders. All respondents
completed Part 1. All Part 1 respondents who met criteria for
any lifetime mental disorder and a probability sample of other
respondents were administered Part 2. Part 2 respondents were
weighted by the inverse of their probability of selection for Part
2 of the interview to adjust for differential sampling. Analyses in
this study were based on the weighted Part 2 subsample, excluding
those individuals with full disability (n=61 259). Additional
weights were used to adjust for differential probabilities of
selection within households, to match the samples to population
sociodemographic distributions and to adjust for non-response
in some of the countries. Standardised interviewer training
procedures, World Health Organization (WHO) translation
protocols for all study material and quality control procedures
for interviewer and data accuracy were consistently applied across
all WMH countries in an effort to ensure cross-national
comparability. Procedures for obtaining informed consent and
protecting participants were approved and monitored for
compliance by the institutional review boards of the
organisations coordinating the surveys in each country. Sampling
and other study characteristics are described elsewhere.15–17
Partial disability
Partial disability days were assessed with a modified version of the
WHO Disability Assessment Schedule II (WHODAS-II).18 The
time frame of the WHODAS-II is the 30 days prior to the
assessment. The interpretation of partial disability days goes
beyond job productivity and focuses instead on the number of
days with functional limitations in daily activities without being
fully out of role. Partial disability was expressed in full day
equivalents to allow for the variation in the number of disability
hours per day. A partial disability day was defined as a day in
which respondents (a) had to cut down on what they did, assessed
by the following item ‘How many days out of the past 30 were you
able to work and carry out your normal activities, but had to cut
down on what you did or not get as much done as usual because
of problems with either your physical health, your mental health,
or your use of alcohol or drugs?’; (b) had to cut back on the
quality of what they did, assessed by the following item: ‘How
many days out of the past 30 did you cut back on the quality of
your work or how carefully you worked because of problems with
either your physical health, your mental health, or your use of
alcohol or drugs?’; and (c) experienced extreme effort to perform
as usual, assessed by the following item: ‘How many days out of
the past 30 did it take an extreme effort to perform up to your
usual level at work or at your other normal daily activities because
of problems with either your physical health, your mental health,
or your use of alcohol or drugs?’. These three items were then
added together in order to calculate an aggregate measure of
partial disability:18,19 number of days people had to cut down
on what they did (0.5); number of days people had to cut back
on quality of what they did (0.5); and number of days they had
extreme effort to perform as usual (0.25). If this sum exceeded
30, it was recoded to equal 30 giving the sum a range from 0 to
30. These four measures (i.e. cut down on quantity, cut back on
quality, took extreme effort and our aggregate measure of partial
disability) were considered as the four dependent variables.
Physical disorders
Physical disorders were assessed with a standard chronic disorders
checklist adapted from the US Health Interview Survey.20 Such
checklists have been shown to yield more complete and accurate
reports than estimates derived from responses to open-ended
questions.21,22 Methodological studies showed moderate to good
concordance between such reports and medical records.23,24 Ten
physical disorders were included in the current report: arthritis,
cancer, cardiovascular disease (heart attack, heart disease,
hypertension and stroke), chronic back or neck pain, diabetes,
frequent or severe headache or migraine, insomnia, neurological
(multiple sclerosis, Parkinson’s disease and epilepsy or seizures),
digestive disease (stomach or intestine ulcer or irritable bowel
disorder) and respiratory disease (seasonal allergies such as hay
fever, asthma or chronic obstructive pulmonary disease or
emphysema). Following standardised procedures for arthritis,
back/neck pain, headache, heart attack or stroke, respondents were
asked to report whether they had experienced these disorders. For
the remaining disorders, the question was prefaced by the phrase
‘Have you ever been told by a doctor or health professional that
you had any of these conditions?’. The time frame varied across
countries and physical disorders: the Western European countries
assessed both lifetime and 12-month presence of each disorder. In
the rest of the sample that used the computer-assisted version of
the questionnaire, some of the chronic disorders were only
evaluated for lifetime presence, but for problems that could have
remitted, participants were asked whether they still had the
disorders in the past 12 months. Finally, those countries using
a paper-assisted questionnaire used a 12-month time frame
for most symptom-based disorders and lifetime frame for the
silent disorders (i.e. individuals not displaying symptoms). The
12-month time frame has been used whenever possible, but for
some of the disorders inconsistent time frames were used across
countries.
Mental disorders
Mental disorders were assessed with Version 3.0 of the WHO
Composite International Diagnostic Interview (CIDI), a fully
structured lay-administered interview designed to generate
research diagnoses of commonly occurring DSM-IV mental
disorders.25 The nine mental disorders considered here include
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mood disorders (major depressive disorder and bipolar I and
bipolar II disorder), anxiety disorders (panic disorder and/or
agoraphobia, specific phobia, social phobia, generalised anxiety
disorder, post-traumatic stress disorder (PTSD)) and substance
disorders (alcohol abuse with and without dependence and drug
abuse with and without dependence). Only disorders present in
the 12 months before interview were considered. Methodological
evidence collected in the WHO CIDI 3.0 field trials and later
clinical calibration studies showed that all disorders considered
here were assessed with acceptable reliability and validity
compared with the original CIDI26 as compared with masked
re-interviews.27
Statistical analysis
We ran multiple regression models to examine the associations of
the independent variables (i.e. the physical and mental disorders)
with each of the four dependent variables, controlling for age,
gender, employment status and country. As the sample size was
too small to allow each of the 524 288 (i.e. 219) logically possible
combinations of comorbid disorders to be a separate predictor,
several regression models were tested (data available from the
author on request). Based on the Bayesian Information Criterion
(BIC), the model that provided the best fit for each of the four
dependent variables (i.e. the model that included 19 predictors
for type and dummy predictors for number of disorders) was
the one that was finally chosen. We calculated both individual
and societal effects of disorders on partial disability. Individual-level
effects refer to the difference in partial disability for those with
and without mental or physical disorders, i.e. the additional
number of days with partial disability for a respondent with a
specific mental/physical disorder. Using simulation, we first
estimated the number of days with partial disability from the final
selected model. Then we calculated this outcome again but based
on the assumption that none of the individuals in the sample had
the disorder or condition being evaluated. Differences between
these two estimates were averaged across all respondents with
the disorder to obtain the individual-level effect of the condition.
Society-level effects were estimated using population attributable
risk proportions (PARPs). From a public health perspective, such
an approach could enable us to identify which disorders will have
the most impact when it comes to making decisions about the
(re)allocation of scarce resources in the general population. The
PARP is to be interpreted as the proportion of partial disability
days in the general population that may be reduced when a
specific disorder is removed. First, estimates of each of the four
disability measures were calculated based on the actual data and
then, second, under the counterfactual assumption that the
disorder in question had been removed from the population.
We used the two estimates of predicted days with partial disability,
and then averaged both estimates across the entire population and
computed the percentage difference between them. The same
procedures were used to calculate total effects of any physical
disorder, any mental disorder and any disorder.
Standard errors for prevalence rates were estimated using the
Taylor series linearisation method28 implemented in the SUDAAN
software package (Software for Survey Data Analysis, version 8.1
on UNIX-Solario/SUN OS) to account for the complex sample
design. Standard errors of individual and societal-level effects were
estimated using SAS macros for Jackknife Repeated Replications
method (JRR) for complex sample data. The macros written for
this purpose were used to obtain standard errors of the simulated
estimates of individual-level and societal-level disorder effects.
Significance tests were consistently evaluated using 0.05-level,
two-sided, design-based tests.
Results
Our sample consisted of 61 259 respondents from 26 surveys:
15 702 from lower-income, 14 473 from middle-income and
31 084 from higher-income countries. Respondents were on
average 42 years old. Almost 52% were female and just above a
third (36.5%) were not married. The proportion of respondents
with completed high-school education varied between 44.8% in
middle- and up to 69.5% in higher-income countries. Overall,
41.3% of the sample was not working. More details on the sample
characteristics can be found elsewhere.15
The distribution of days with partial disability
The mean number of days with partial disability was 1.6 a month
(Table 1). About one in five (i.e. 21.6%) reported at least 1 day
with partial disability in the previous month. Among these, the
average number of days with partial disability days approximated
7.3 per month.
Prevalence of physical and mental disorders
More than half (57.2%) of the respondents had one or more
disorders. The proportion of respondents with a physical
condition (52.6%) is considerably higher than the proportion with
a mental disorder (14.9%). Back/neck pain, cardiovascular disease
and respiratory disease were the most common physical disorders
(all estimates in the 17–22% range). Major depression episode,
specific phobia and social phobia were the most common mental
disorders (all in the 2–5% range) (online Table DS1). Prevalence
estimates of physical disorders increased with income level:
44.9% in low-, 51.7% in middle- and 56.9% in high-income
countries. Comparable figures were obtained for the prevalence
of mental disorders: 11.8% in low-, 15.1% in middle- and
16.4% in high-income countries (online Table DS2).
Partial disability among respondents with physical
and mental disorders
The average number of partial disability days varied considerably
by type of disorder, but were in the 2.38–4.57 range for people
with physical disorders (median 3.31 days) and in the 2.40–5.84
range for mental disorders (median 4.37 days). Post-traumatic
stress disorder (5.84 days), generalised anxiety disorder (4.96 days)
and bipolar disorder (4.60 days) were the disorders with the
highest number of partial disability days. Overall, respondents
with mental disorders systematically reported 15–28% more
partial disability days than respondents with physical disorders.
When partial disability days were broken down into the three
subdomains, the impact of disorders appeared to be comparable
(online Table DS1).
Individual-level effects of physical and mental
disorders on partial disability days
Table 2 shows the additional days per month with partial disability
in respondents with a physical/mental disorder compared with
those without. The presence of a disorder was associated with
an additional 1.58 disability days/month (or 19 days/year).
Specifically, PTSD (1.92 additional days/month), depression
(1.65 additional days/month) and bipolar disorder (1.70
additional days/month) were among the disorders with the
highest additional partial disability. Mental and physical disorders
yielded comparable disability, a finding that was slightly more
pronounced in high-income countries. Indeed, the estimated
impact of disorders was higher in high-income (1.91 additional
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days/month) than middle-income (1.14 additional days/month)
or lower-income countries (1.15 additional days/month; online
Table DS3).
The multivariate interactive regression model revealed that all
19 disorders were significantly associated with additional partial
disability days, even when data were broken down for the three
subdomains (online Table DS4). Depression and bipolar disorder
were most predictive in this multivariate model. Interestingly, the
coefficients associated with the number of disorders did not
change considerably with increasing number of disorders. From
the 15 coefficients investigated (five groups of dummies for
number of disorders by three partial disability subdomains; online
Table DS4), only 5 were significant. This indicates additive
interactions among disorders; that is, the joint effects of multiple
disorders are additive to those of individual disorders.
Society-level effects of physical and mental disorders
on partial disability days
Table 3 shows the PARP of days with partial disability caused by
mental and physical disorders. The PARPs for physical disorders
were considerably higher than those for mental disorders
(49.2% v. 14.7%). Back/neck pain (PARP= 21.01%), arthritis
(PARP= 7.82%) and cardiovascular disease (PARP= 7.22%) were
the disorders that yielded the highest attributable risk (see also
online Table DS5). When data were disaggregated for each of
the three domains of partial disability, back/neck pain was among
the disorders having the greatest impact on each of the three
domains, with PARPs all in the 17–27% range (Table 3). A
summary of PARP estimates is found in Fig. 1.
Discussion
Both physical and mental disorders are associated with
considerable partial disability. Respondents with PTSD,
generalised anxiety disorder, insomnia, bipolar disorder or panic
disorder report up to 50 days per year with partial disability.
On average, a person with any disorder reported about 19
additional partial disability days per year. This finding was more
pronounced in high-income (23 additional days) than in middle-
and low-income countries (about 14 additional days). In
particular, PTSD, depression and bipolar disorder yielded the
greatest impact. By contrast, at the societal level, physical disorders
yielded the highest PARPS; these accounted for 49% of the
observed partial disability, compared with only 15% accounted
for by mental disorders.
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Table 1 Distribution of partial disability in the World Mental Health Surveys
Low-income
countries
Middle-income
countries
High-income
countries
Total
sample
Had to cut down quantity
Any days had to cut down quantity, % (s.e.) 16.2 (0.4) 13.0 (0.4) 19.0 (0.3) 16.8 (0.2)
1 day 12.9 (0.9) 10.5 (0.9) 12.8 (0.5) 12.4 (0.4)
2 days 22.3 (1.2) 16.0 (1.1) 16.8 (0.6) 18.0 (0.5)
3–5 days 27.5 (1.1) 24.2 (1.1) 25.5 (0.7) 25.8 (0.5)
6–10 days 18.8 (1.2) 15.2 (1.0) 14.7 (0.6) 15.8 (0.5)
11–20 days 10.1 (0.8) 11.9 (0.9) 12.2 (0.5) 11.7 (0.4)
21–30 days 8.5 (0.8) 22.1 (1.2) 17.9 (0.7) 16.4 (0.5)
Number of cut down days, mean (s.e.) 1.2 (0.05) 1.4 (0.06) 1.9 (0.05) 1.6 (0.03)
Number of cut down days, among those with any cut down days: mean (s.e.) 7.3 (0.2) 11.1 (0.3) 9.9 (0.2) 9.5 (0.1)
Had to cut back quality
Any days had to cut back quality, % (s.e.) 13.1 (0.4) 9.2 (0.3) 14.7 (0.3) 13.0 (0.2)
1 day 12.4 (1.1) 11.7 (1.0) 12.3 (0.6) 12.3 (0.5)
2 days 21.3 (1.4) 16.8 (1.2) 18.5 (0.7) 18.9 (0.6)
3–5 days 31.2 (1.4) 31.4 (1.5) 29.9 (0.8) 30.5 (0.6)
6–10 days 19.3 (1.3) 17.0 (1.4) 14.9 (0.6) 16.4 (0.5)
11–20 days 10.0 (0.9) 12.5 (1.0) 11.6 (0.6) 11.3 (0.5)
21–30 days 5.7 (0.7) 10.7 (0.9) 12.7 (0.6) 10.6 (0.4)
Number of cut back days, mean (s.e.) 0.9 (0.03) 0.8 (0.04) 1.2 (0.03) 1.0 (0.02)
Number of cut back days, among those with any cut back days: mean (s.e.) 6.7 (0.2) 8.3 (0.3) 8.5 (0.2) 8.0 (0.1)
Took extreme effort
Any days took extreme effort, % (s.e.) 11.8 (0.3) 9.4 (0.3) 16.3 (0.3) 13.5 (0.2)
1 day 11.2 (1.1) 11.8 (1.4) 12.4 (0.6) 12.1 (0.5)
2 days 17.2 (1.2) 15.9 (1.2) 17.5 (0.6) 17.1 (0.5)
3–5 days 31.3 (1.5) 29.7 (1.6) 27.2 (0.7) 28.5 (0.6)
6–10 days 21.5 (1.3) 18.2 (1.4) 16.6 (0.7) 17.9 (0.5)
11–20 days 10.0 (0.8) 11.2 (0.9) 11.3 (0.6) 11.0 (0.4)
21–30 days 8.8 (0.9) 13.2 (1.0) 15.1 (0.6) 13.4 (0.5)
Number of extreme effort days, mean (s.e.) 0.9 (0.04) 0.8 (0.04) 1.5 (0.04) 1.2 (0.02)
Number of extreme effort days, among those with any extreme effort days: mean (s.e.) 7.7 (0.3) 8.8 (0.3) 9.1 (0.2) 8.7 (0.1)
Partial disability
Any days with partial disability, % (s.e.) 19.7 (0.4) 15.4 (0.5) 25.4 (0.4) 21.6 (0.2)
1 day 20.3 (1.0) 15.6 (0.9) 19.2 (0.5) 18.9 (0.4)
2 days 15.7 (0.9) 14.5 (0.9) 16.0 (0.6) 15.7 (0.4)
3–5 days 26.5 (1.2) 21.8 (1.1) 23.7 (0.5) 24.0 (0.5)
6–10 days 16.9 (0.9) 15.1 (0.8) 14.4 (0.5) 15.1 (0.4)
11–20 days 15.2 (0.7) 23.9 (1.1) 16.8 (0.5) 17.6 (0.4)
21–30 days 5.4 (0.6) 9.2 (0.7) 9.9 (0.4) 8.7 (0.3)
Number of days with partial disabilities, mean (s.e.) 1.2 (0.04) 1.3 (0.05) 1.9 (0.04) 1.6 (0.03)
Number of days with partial disability among those with any partial disability, mean (s.e.) 6.2 (0.2) 8.2 (0.2) 7.4 (0.1) 7.3 (0.1)
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Limitations
These results should be interpreted in the light of the following
limitations. First, only a restricted set of common mental and
physical disorders was included in the analyses; some of these were
pooled to form larger disorder groups. A number of burdensome
disorders, such as dementia and psychosis, were not included.
Nonetheless, the disorders we did consider included many of those
most commonly reported in previous population studies.8 Further
study should focus on possibly high-impact disorders that were
not included in the present study. A second limitation pertains
to the self-report method we used to assess physical disorders.
Since the WMH Surveys were conducted in many population
samples, it was not feasible to include a more comprehensive
assessment of physical disorders. Although prior research has
demonstrated reasonable correspondence between self-reported
chronic disorders (such as diabetes, heart disease and asthma) and
general practitioner records,29 previous studies have suggested that
self-report measures may be more amenable to underreporting bias
than behavioural measures or physical examinations. Indeed,
these may be biased by cultural norms30,31 or demographic factors
(such as lower education or poor health literacy). There is even
some evidence that that self-reported somatic disorders tend to
be forgotten.32,33 This suggests that we may have underestimated
the contribution of somatic disorders to partial disability. Third,
the time frame in which we assessed partial disability was limited
to the 30 days prior to the interview, in order to increase the
validity of self-reports. Despite this, for more episodic disorders,
the recall period might have missed a severe exacerbation present
in the previous year, but not in the month before the interview.
Main findings
Notwithstanding these limitations, several findings from the
present study extend the existing literature. For a given respondent,
mental disorders (mostly depression, bipolar disorder and PTSD)
are associated with a significant additional increase in partial
disability days, even after rigorously controlling for a broad set
of sociodemographic variables and comorbidity. These findings
extend earlier work8,13,34–36 by showing that mental disorders
are associated with partial disability, over and above full disability.
To the best of our knowledge, our study is the first cross-national
study comparing the relative impact of disorders in respondents
who indicate that they are not fully out of role in their daily
functioning. Some of the results we found differed from those
in previous studies.9 This could be the result of some
methodological differences between this and previous studies.
For example, previous studies often did not adjust disability for
comorbidity patterns of disorders. We also extend previous
findings by investigating decrements in day-to-day functioning
that go beyond mere job productivity4 and instead focus on a
broader understanding of functioning.
The set of physical and mental disorders included in this study
accounted for more than half of all partial disability days. If we
look at individual mental disorders, depression in particular is
of interest given its relatively high 12-month prevalence (45%),
its considerable effect on partial disability (about 20 additional
days per year), as well as its relatively high population attributable
risk (about 6%). By contrast, among physical disorders, back/neck
pain is of interest because it is a highly prevalent condition (with
estimates around 22%) yielding 18 additional disability days per
year. Moreover, approximately a fifth of all partial disability was
attributable to this condition. The same pattern applies to
arthritis, but to a lesser extent. It is interesting that previous
studies, although they often used different methodological
approaches, also ranked back/neck pain and depression as being
among the disorders having the greatest impact both at the
individual and societal level.7,37,38 From a public health
perspective, depression and back/neck pain may be a focus for
prioritisation when deciding upon resource allocation.
For a given respondent, the type of partial disability caused by
disorders is quite similar: mental disorders cause about 14–16
additional days with partial disability per year. Comparable figures
for physical disorders were 13–15 additional disability days. We
could not confirm that mental disorders (compared with physical
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Table 2 Additional partial disability days associated with mental and physical disorders: individual-level effects
Additional cut down
days
Additional cut back
days
Additional extreme
effort days
Any additional partial
disability
Mean (s.e.) Rank Mean (s.e.) Rank Mean (s.e.) Rank Mean (s.e.) Rank
Disorder
Depression 1.30 (0.16) 5 1.28 (0.15) 2 1.57 (0.16) 2 1.65 (0.18) 3
Bipolar disorder 1.47 (0.35) 2 1.28 (0.34) 3 1.14 (0.36) 6 1.70 (0.45) 2
Panic disorder 1.06 (0.27) 8 0.98 (0.22) 8 1.22 (0.23) 5 1.28 (0.24) 7
Specific phobia 0.41 (0.14) 17 0.61 (0.16) 13 0.74 (0.17) 13 0.70 (0.16) 15
Social phobia 0.76 (0.21) 11 0.79 (0.17) 9 0.93 (0.20) 11 0.95 (0.24) 10
Generalised anxiety disorder 1.37 (0.32) 3 0.99 (0.33) 7 0.98 (0.29) 9 1.35 (0.39) 6
Alcohol abuse 0.36 (0.18) 18 0.32 (0.16) 18 0.23 (0.17) 19 0.41 (0.19) 18
Drug abuse 0.43 (0.35) 16 0.67 (0.36) 12 0.84 (0.39) 12 0.77 (0.50) 13
Post-traumatic stress disorder 1.60 (0.30) 1 1.62 (0.30) 1 1.66 (0.30) 1 1.92 (0.42) 1
Insomnia 1.36 (0.21) 4 1.14 (0.16) 4 1.36 (0.19) 4 1.52 (0.21) 4
Headache or migraine 0.53 (0.11) 15 0.52 (0.10) 17 0.57 (0.11) 16 0.67 (0.19) 17
Arthritis 0.84 (0.13) 10 0.54 (0.10) 16 0.73 (0.10) 14 0.83 (0.17) 12
Back/neck pain 1.25 (0.11) 6 1.12 (0.09) 5 1.38 (0.10) 3 1.49 (0.28) 5
Cardiovascular disease 0.63 (0.13) 13 0.55 (0.10) 15 0.51 (0.10) 17 0.67 (0.20) 16
Respiratory disease 0.25 (0.10) 19 0.26 (0.08) 19 0.26 (0.09) 18 0.31 (0.13) 19
Diabetes 0.60 (0.20) 14 0.60 (0.17) 14 0.73 (0.19) 15 0.73 (0.21) 14
Digestive 0.75 (0.22) 12 0.70 (0.20) 11 0.93 (0.21) 10 0.87 (0.26) 11
Neurological 1.15 (0.35) 7 1.01 (0.31) 6 1.11 (0.38) 7 1.21 (0.52) 8
Cancer 1.00 (0.31) 9 0.77 (0.22) 10 0.98 (0.25) 8 1.03 (0.33) 9
Any physical disorder 1.26 (0.07) – 1.05 (0.04) – 1.24 (0.05) – 1.42 (0.25) –
Any mental disorder 1.21 (0.08) – 1.18 (0.07) – 1.37 (0.07) – 1.50 (0.12) –
Any disorder 1.38 (0.07) – 1.16 (0.04) – 1.37 (0.05) – 1.58 (0.24) –
Partial disability and common mental and physical disorders
disorders) were more likely associated with an increase in both the
number of partial and total disability days, as suggested in
previous research. Indeed, Dewa and colleagues5 found that
mental disorders yielded 23 times more total disability days than
partial disability days. If we compare the impact of mental/
physical disorders on both the number of days where respondents
were totally out of role13 or partially out of role (this study), it is
striking that the impact of mental disorders is quite similar to that
of physical disorders. In line with this, it was also suggested that
mental and physical disorders were similar in their impact on costs
of illness.39
The impact of disorders on partial disability was most
pronounced in high-income countries. In low-income countries,
estimates of both individual and societal effects of mental
disorders on partial disability were systematically 33–50% lower
than those of middle- or high-income countries. This was also
the case for physical disorders, although to a lesser extent (i.e.
about 15–46%). The impact of disorders on partial disability
was consistently lower in low-income countries, in contrast to the
effect disorders have on days totally out of role.13 As this is the first
study that investigated cross-income effects, further research should
point us to whether these effects can be confirmed.
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Table 3 The association between mental and physical disorders and days with partial disability: society-level effects presented
as population attributable risk proportions
Additional cut down
days
Additional cut back
days
Additional extreme
effort days
Any additional partial
disability
Mean (s.e.) Rank Mean (s.e.) Rank Mean (s.e.) Rank Mean (s.e.) Rank
Disorder
Depression 4.49 (0.55) 5 6.90 (0.84) 5 7.60 (0.77) 3 5.86 (1.23) 5
Bipolar disorder 0.69 (0.17) 17 0.93 (0.25) 17 0.75 (0.24) 17 0.82 (0.35) 17
Panic disorder 1.22 (0.31) 13 1.76 (0.40) 13 1.97 (0.38) 12 1.51 (0.48) 12
Specific phobia 1.33 (0.46) 12 3.09 (0.81) 8 3.35 (0.78) 8 2.32 (0.67) 8
Social phobia 1.14 (0.32) 14 1.83 (0.41) 12 1.95 (0.41) 13 1.46 (0.62) 13
Generalised anxiety disorder 1.14 (0.27) 15 1.28 (0.43) 15 1.15 (0.35) 15 1.15 (0.51) 15
Alcohol abuse 0.47 (0.23) 18 0.66 (0.33) 18 0.43 (0.32) 19 0.55 (0.32) 18
Drug abuse 0.16 (0.13) 19 0.38 (0.20) 19 0.43 (0.20) 18 0.29 (0.23) 19
Post-traumatic stress disorder 1.42 (0.28) 10 2.23 (0.44) 10 2.06 (0.40) 11 1.75 (0.70) 11
Insomnia 4.08 (0.64) 6 5.30 (0.76) 6 5.72 (0.81) 6 4.69 (0.91) 6
Headache or migraine 4.61 (0.99) 4 7.06 (1.35) 4 6.94 (1.31) 5 5.99 (1.03) 4
Arthritis 7.70 (1.23) 2 7.65 (1.45) 3 9.43 (1.29) 2 7.82 (1.31) 2
Back/neck pain 17.17 (1.55) 1 24.03 (1.95) 1 26.65 (1.85) 1 21.01 (2.43) 1
Cardiovascular disease 6.56 (1.35) 3 8.99 (1.64) 2 7.50 (1.51) 4 7.22 (1.30) 3
Respiratory disease 2.75 (1.06) 7 4.38 (1.45) 7 4.02 (1.36) 7 3.53 (1.13) 7
Diabetes 1.50 (0.51) 9 2.37 (0.66) 9 2.58 (0.66) 10 1.90 (0.83) 9
Digestive 1.52 (0.44) 8 2.20 (0.65) 11 2.65 (0.60) 9 1.83 (0.84) 10
Neurological 0.78 (0.24) 16 1.07 (0.33) 16 1.06 (0.36) 16 0.85 (0.51) 16
Cancer 1.35 (0.42) 11 1.61 (0.46) 14 1.85 (0.48) 14 1.43 (0.69) 14
Any physical disorder 42.23 (2.20) – 54.89 (2.28) – 58.47 (1.96) – 49.15 (4.88) –
Any mental disorder 11.53 (0.80) – 17.47 (1.13) – 18.29 (0.96) – 14.73 (3.96) –
Any disorder 50.51 (2.55) – 66.11 (2.51) – 70.01 (2.29) – 59.42 (6.75) –
P
o
p
u
la
tio
n
at
tr
ib
u
ta
b
le
ri
sk
p
ro
p
o
rt
io
n
s
Cut down days
Cut back days
Extreme effort days
Any partial disability
80 –
70 –
60 –
50 –
40 –
30 –
20 –
10 –
0 –
Mental disorder Physical disorder Any disorder
Fig. 1 Estimated proportion of partial disability attributable to common mental and physical disorders in the World Mental Health
Surveys (population attributable risk proportions).
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Implications
The results obtained in this study may have some important
implications. Given that mental and physical disorders yield a
similar impact on partial disability, this sheds light on the
importance of prioritising public health needs. To the extent that
partial disability may be a predictor of full disability,12 our data
underscore the importance of including partial disability when
evaluating functional impairment. Our data indicate that a
reduction in depression and back/neck pain could be considered
as a public health priority, especially given the knowledge that
these disorders (a) have a high impact at both an individual and
societal level; (b) cause both full disability and partial disability
days; and (c) have a considerable comorbidity in both clinical
and general population settings.40 How this may be done at
country level remains an open question. Prevention, integrated
treatment and supportive services have been suggested,41 but the
alleviation of this substantial burden of ill health, in both personal
and economic terms, remains a significant challenge.
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